Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the tezspire market size evolved in recent years?

In recent years, the tezspire market has seen an XX (HCAGR) expansion. Forecasts indicate a growth from $XX million in 2024 to $XX million in 2025, equating to a compound annual growth rate (CAGR) of XX%. This growth during the reviewed period can be ascribed to a heightened prevalence of serious asthma, the need for more successful treatments, an increased awareness of biologic therapies and an upswing in clinical trials.

What are the predictions for the tezspire market size in the coming years?

Predictions indicate a significant increase in the tezspire market size in the forthcoming years, with an expected XX (FCAGR). The market is anticipated to escalate to $XX million in 2029, marking a compound annual growth rate (CAGR) of XX%. The projected growth during this period can be associated with several factors including expanded pediatric indications, surge in asthma diagnoses, increased use of biologics in asthma treatment, and the go up in health expenditure in emerging markets. Emerging trends over this forecast period correspondingly display a progression towards biologic therapies, an emphasis on early intervention and prevention strategies, an uptake in subcutaneous self-administration treatments, a transition towards digital health solutions for asthma management and heightened patient-centric treatment approaches.

Get your tezspire market report here!

https://www.thebusinessresearchcompany.com/report/tezspire-global-market-report

What key factors are fueling the growth of the tezspire market?

The escalating occurrences of asthma are anticipated to boost the tezspire market’s expansion in the future. Characterized by inflamed and tightened airways, asthma is a long-term respiratory disease causing difficulty in breathing, wheezing, coughing and shortness of breath. The surge in asthma cases can be attributed to rising environmental pollution and changing lifestyles leading to an increased exposure to allergens and respiratory irritants. Tezspire, a precision biologic treatment, aids in managing severe asthma by restraining a critical protein involved in inflammation, minimizing flare-ups, and providing relief for patients who are resistant to conventional therapies. For example, the Greater London Authority, a UK-based governing body, reported in November 2022 that in the period of 2021/22, over 3,600 children were admitted into hospital due to asthma in London, which represents a considerable increase of 64 percent compared to the previous year. Consequently, the growing rate of botulism incidents is fuelling the tezspire market’s growth.

How is the global tezspire market divided into key segments?

The tezspire market covered in this report is segmented –

1) By Indication: Asthma; Chronic Obstructive Pulmonary Disease; Chronic Rhinosinusitis; Chronic Spontaneous Urticaria; Eosinophilic Esophagitis

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By End User: Adult Patients; Pediatric Patients

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20362&type=smp

Who are the key firms paving the way for growth in the tezspire market?

Major companies operating in the tezspire market are AstraZeneca plc; Amgen Inc.

Which trends are expected to transform the tezspire market?

One prevailing trend in the Tezspire market is the acquisition of regulatory consents for wider applications, particularly in asthma and possibly other prolonged inflammatory conditions. These regulatory consents are official permissions given by health agencies such as the FDA or EMA, permitting the marketing and use of a drug or therapy based on verified safety, effectiveness and quality. A notable instance of this occurred in February 2023, when UK-based pharmaceutical company, AstraZeneca Plc., secured approval for Tezspire (tezepelumab-ekko), meant to be self-administered by patients aged 12 and above suffering from severe asthma. This was developed together with US-based biotech company, Amgen Inc. This approval gives patients the ability to administer the drug themselves at home after adequate training. The clearance was endorsed by data from the PATHFINDER clinical trial program, which revealed a substantial majority of participants were able to self-administer the treatment. Tezspire is distinct, being the first biologic for severe asthma that doesn’t have restrictions based on phenotype or biomarker status, thereby extending treatment options.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20362

What regions are contributing significantly to the growth of the tezspire market?

North America was the largest region in the tezspire market in 2024. The regions covered in the tezspire market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Global Hospital Acquired Infections Testing Kits Global Market Report 2025

https://thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-market

Anti-Inflammatory Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: